Dorothea Nitsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorothea Nitsch has a total of 517 co-authors. Here are the top co-authors by number of shared publications:
- Laurie A. Tomlinson
Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
9 shared publications Retha Steenkamp
UK Renal Registry, UK Kidney Association, London, UK
8 shared publicationsLiam Smeeth
6 shared publications- Ben Caplin
Department of Renal Medicine, University College London, London, UK
5 shared publications - Helen I. McDonald
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
5 shared publications - Masao Iwagami
Department of Digital Health, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
5 shared publications
Latest Publications
- Open Access
- 18 October 2026
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 35 (11) , e70507
Evaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All‐Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data
Purpose: Anaemia is a common complication of chronic kidney disease, often treated with erythropoiesis‐stimulating agents (ESAs), but the optimal haemoglobin (Hb) target remains uncertain. Using electronic health records, we emulated a target trial comparing different Hb targets in haemodialysis patients to estimate their effects on mortality. Methods: We used electronic health records from UK kidney centres reporting to the UK Renal Registry. Adults aged ≥ 18 years, receiving haemodialysis for ≥ 3 months, and without marked ESA resistance were eligible. Using the clone‐censor‐weight method, we emulated trials comparing Hb targets: (1) 105–125 versus 95–115 g/L and (2) 125–145 versus 95–115 g/L. Darbepoetin dosing followed a standardised protocol with predefined dose adjustments and a maximum dose of 150 μg/week. The outcome was all‐cause mortality over 8 months. Results: The study included 8628 patients from 10 centres between 2004 and 2016; 62% male, median age 66 years (IQR 52–76). At baseline, mean Hb was 97.7 g/L (SD 15.1), and 79% of patients were receiving darbepoetin. The hazard ratio for mortality was 0.92 (95% CI 0.75–1.12) for the 105–125 versus 95–115 g/L comparison, and 1.20 (95% CI 0.94–1.54) for the 125–145 versus 95–115 g/L comparison. Adherence to the highest Hb target was lower, limiting precision. Conclusions: Targeting an Hb range of 105–125 g/L under controlled ESA dosing was not associated with increased mortality compared with 95–115 g/L. Targeting Hb levels above 125 g/L may increase mortality risk, consistent with previous trial findings.
- 18 October 2026
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 35 (11) , e70507
Open AccessEvaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All‐Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data
Purpose: Anaemia is a common complication of chronic kidney disease, often treated with erythropoiesis‐stimulating agents (ESAs), but the optimal haemoglobin (Hb) target remains uncertain. Using electronic health records, we emulated a target trial comparing different Hb targets in haemodialysis patients to estimate their effects on mortality. Methods: We used electronic health records from UK kidney centres reporting to the UK Renal Registry. Adults aged ≥ 18 years, receiving haemodialysis for ≥ 3 months, and without marked ESA resistance were eligible. Using the clone‐censor‐weight method, we emulated trials comparing Hb targets: (1) 105–125 versus 95–115 g/L and (2) 125–145 versus 95–115 g/L. Darbepoetin dosing followed a standardised protocol with predefined dose adjustments and a maximum dose of 150 μg/week. The outcome was all‐cause mortality over 8 months. Results: The study included 8628 patients from 10 centres between 2004 and 2016; 62% male, median age 66 years (IQR 52–76). At baseline, mean Hb was 97.7 g/L (SD 15.1), and 79% of patients were receiving darbepoetin. The hazard ratio for mortality was 0.92 (95% CI 0.75–1.12) for the 105–125 versus 95–115 g/L comparison, and 1.20 (95% CI 0.94–1.54) for the 125–145 versus 95–115 g/L comparison. Adherence to the highest Hb target was lower, limiting precision. Conclusions: Targeting an Hb range of 105–125 g/L under controlled ESA dosing was not associated with increased mortality compared with 95–115 g/L. Targeting Hb levels above 125 g/L may increase mortality risk, consistent with previous trial findings.
- Open Access
- 16 September 2026
- Published by Wiley in Diabetic Medicine
- p. e70465
Associations between prior wasting malnutrition and indices of insulin secretion and sensitivity among six cohorts from Asia and Africa: The SAMPA study
Aims: The role of prior wasting malnutrition (PM) in determining insulin sensitivity and secretion in low‐ and middle‐income countries (LMICs) remains unclear. We investigated associations of insulin indices with PM and whether these were modified by current body mass index (BMI). Methods: Participants were enrolled from child and adult cohorts in Zambia, Tanzania, India and the Philippines with previously documented PM or no prior wasting malnutrition (NPM). Plasma glucose, insulin and C‐peptide were measured during an oral glucose tolerance test. Static (HOMA2 %S, HOMA2 %B) and dynamic (Matsuda index, insulinogenic index, disposition index) insulin indices were calculated. Adjusted linear regression models compared indices between PM and NPM groups. Results: In 2172 participants analysed, those with PM had lower current BMI. Children with PM had reduced insulin sensitivity (Matsuda index 20%–24% lower in PM vs. NPM). Adults with PM in early life (36–37 years before) many of whom had high adult BMI, also exhibited lower insulin sensitivity after adjustment for current BMI (Matsuda Index 18% lower in PM vs. NPM). Adults with more recent PM (3–17 years previously), many of whom remained underweight, had low insulin secretion (HOMA2 %B 10%–20% lower in PM vs. NPM) but greater insulin sensitivity associated with their lower BMI (Matsuda index 21%–47% higher in PM vs. NPM). Insulin secretion generally compensated for insulin sensitivity differences, maintaining comparable disposition index and diabetes and prediabetes prevalence between PM and NPM groups. Conclusions: PM affects glucose metabolism differently according to current BMI. Remaining underweight is associated with low insulin secretion and weight gain following PM is linked to reduced insulin sensitivity. Our results further inform understanding of the relative roles of reduced insulin secretion and sensitivity in diabetes pathogenesis in LMICs.
- 16 September 2026
- Published by Wiley in Diabetic Medicine
- p. e70465
Open AccessAssociations between prior wasting malnutrition and indices of insulin secretion and sensitivity among six cohorts from Asia and Africa: The SAMPA study
Aims: The role of prior wasting malnutrition (PM) in determining insulin sensitivity and secretion in low‐ and middle‐income countries (LMICs) remains unclear. We investigated associations of insulin indices with PM and whether these were modified by current body mass index (BMI). Methods: Participants were enrolled from child and adult cohorts in Zambia, Tanzania, India and the Philippines with previously documented PM or no prior wasting malnutrition (NPM). Plasma glucose, insulin and C‐peptide were measured during an oral glucose tolerance test. Static (HOMA2 %S, HOMA2 %B) and dynamic (Matsuda index, insulinogenic index, disposition index) insulin indices were calculated. Adjusted linear regression models compared indices between PM and NPM groups. Results: In 2172 participants analysed, those with PM had lower current BMI. Children with PM had reduced insulin sensitivity (Matsuda index 20%–24% lower in PM vs. NPM). Adults with PM in early life (36–37 years before) many of whom had high adult BMI, also exhibited lower insulin sensitivity after adjustment for current BMI (Matsuda Index 18% lower in PM vs. NPM). Adults with more recent PM (3–17 years previously), many of whom remained underweight, had low insulin secretion (HOMA2 %B 10%–20% lower in PM vs. NPM) but greater insulin sensitivity associated with their lower BMI (Matsuda index 21%–47% higher in PM vs. NPM). Insulin secretion generally compensated for insulin sensitivity differences, maintaining comparable disposition index and diabetes and prediabetes prevalence between PM and NPM groups. Conclusions: PM affects glucose metabolism differently according to current BMI. Remaining underweight is associated with low insulin secretion and weight gain following PM is linked to reduced insulin sensitivity. Our results further inform understanding of the relative roles of reduced insulin secretion and sensitivity in diabetes pathogenesis in LMICs.
- Open Access
Assessing EHR potential for adaptive learning in multimorbidity care in Sub-Saharan Africa: a mixed-methods study of Zimbabw’s Impilo system
Electronic health records (EHR) are increasingly recognised as critical digital infrastructure for integrated, patient-centred care in the context of rising multimorbidity. In low-resource settings, national EHRs may also support locally driven learning to improve adaptive care across chronic conditions. However, there is limited empirical evidence on whether and how these systems enable learning within routine care in ways that inform broader system adaptation. We conducted a qualitative multi-method assessment of Impilo, Zimbabw’s national EHR, to examine its capacity to support learning for integrated multimorbidity care at primary care level, using HIV-hypertension as a tracer condition pair. Guided by Friedman’s socio-technical infrastructure model as the analytical framework and Learning Health Systems (LHS) theory as the interpretive framework, data were drawn from documentary review, ethnographic observation, patient journey mapping, and interviews with frontline health workers and key stakeholders. Frontline learning for person-centred multimorbidity care was actively generated through interpretation of patient trajectories, experiential adjustment, and coordination across HIV and hypertension services using both the EHR and paper-based artefacts such as registers and patient booklets. However, this learning remained largely encounter-bound and weakly stabilised. Impilo did not routinely provide usable longitudinal patient views, practice-facing analytic tools, or institutionalised mechanisms for collective reflection required to support integrated multimorbidity care. Consequently, learning was largely confined to incremental adjustment within existing workflows, with limited capacity to inform broader changes to care pathways, routines, or system design. These findings suggest that the principal barrier to developing LHS is not the absence of data or frontline learning capacity, but the lack of socio-technical arrangements that enable learning to stabilise and inform system adaptation. Digitalisation alone is insufficient to support adaptive multimorbidity care. Co-production with frontline health workers may provide a pathway for aligning digital system design with routine care realities. Author summary: Electronic health records are increasingly used to support integrated care for people living with multiple long-term conditions, including HIV and hypertension. However, they practically remain organised around single diseases and reporting requirements, limiting their ability to support coordinated, person-centred care. We studied Zimbabw’s national electronic health record system, Impilo, to understand how it supports integrated HIV and hypertension care in primary healthcare settings. We found that frontline health workers routinely generated practical knowledge by interpreting patient histories, coordinating care across services, and combining paper and electronic records to maintain continuity of care. However, much of this learning remained informal and tied to individual patient encounters because the system did not routinely provide longitudinal patient views, coordinated follow-up, or integrated information across conditions. Our findings suggest that the main challenge is not a lack of data, digital systems, or frontline expertise, but the limited ability of current systems to support learning and adaptation for multimorbidity care. Involving frontline health workers in the design and improvement of electronic health records may help create more integrated, learning-oriented health systems.
Open AccessAssessing EHR potential for adaptive learning in multimorbidity care in Sub-Saharan Africa: a mixed-methods study of Zimbabw’s Impilo system
Electronic health records (EHR) are increasingly recognised as critical digital infrastructure for integrated, patient-centred care in the context of rising multimorbidity. In low-resource settings, national EHRs may also support locally driven learning to improve adaptive care across chronic conditions. However, there is limited empirical evidence on whether and how these systems enable learning within routine care in ways that inform broader system adaptation. We conducted a qualitative multi-method assessment of Impilo, Zimbabw’s national EHR, to examine its capacity to support learning for integrated multimorbidity care at primary care level, using HIV-hypertension as a tracer condition pair. Guided by Friedman’s socio-technical infrastructure model as the analytical framework and Learning Health Systems (LHS) theory as the interpretive framework, data were drawn from documentary review, ethnographic observation, patient journey mapping, and interviews with frontline health workers and key stakeholders. Frontline learning for person-centred multimorbidity care was actively generated through interpretation of patient trajectories, experiential adjustment, and coordination across HIV and hypertension services using both the EHR and paper-based artefacts such as registers and patient booklets. However, this learning remained largely encounter-bound and weakly stabilised. Impilo did not routinely provide usable longitudinal patient views, practice-facing analytic tools, or institutionalised mechanisms for collective reflection required to support integrated multimorbidity care. Consequently, learning was largely confined to incremental adjustment within existing workflows, with limited capacity to inform broader changes to care pathways, routines, or system design. These findings suggest that the principal barrier to developing LHS is not the absence of data or frontline learning capacity, but the lack of socio-technical arrangements that enable learning to stabilise and inform system adaptation. Digitalisation alone is insufficient to support adaptive multimorbidity care. Co-production with frontline health workers may provide a pathway for aligning digital system design with routine care realities. Author summary: Electronic health records are increasingly used to support integrated care for people living with multiple long-term conditions, including HIV and hypertension. However, they practically remain organised around single diseases and reporting requirements, limiting their ability to support coordinated, person-centred care. We studied Zimbabw’s national electronic health record system, Impilo, to understand how it supports integrated HIV and hypertension care in primary healthcare settings. We found that frontline health workers routinely generated practical knowledge by interpreting patient histories, coordinating care across services, and combining paper and electronic records to maintain continuity of care. However, much of this learning remained informal and tied to individual patient encounters because the system did not routinely provide longitudinal patient views, coordinated follow-up, or integrated information across conditions. Our findings suggest that the main challenge is not a lack of data, digital systems, or frontline expertise, but the limited ability of current systems to support learning and adaptation for multimorbidity care. Involving frontline health workers in the design and improvement of electronic health records may help create more integrated, learning-oriented health systems.
- Open Access
- 6 July 2026
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
Trends in mortality of people on dialysis in England and Wales over the last 15 years
Background: Traditionally cardiovascular death has been the major cause of death for kidney dialysis patients. Aim: To investigate trends in mortality over the past 15 years using UK Renal Registry (UKRR) data and the impact of age, sex, ethnicity and social deprivation. Methods: Incidence rates of all-cause mortality, cardiovascular mortality, mortality from infection and from dialysis withdrawal at 1 year after starting dialysis were calculated for incident patients. Comparisons by sex, deprivation-quintile and ethnicity used age-standardization to account for the change in the age profile over time. Results: All-cause mortality in haemodialysis patients within 1 year of starting reduced from 212/1000 patient years (py) in 2008 to 154 per 1000 py in 2022; although lower for peritoneal dialysis there was no improvement (67/1000 py to 82/1000 py). This decrease in mortality was greatest for older dialysis starters with no major changes in younger age-groups. There was no evidence of a difference in trends of all-cause or cardiovascular mortality by sex, ethnicity or deprivation quintiles. There was no improvement in infection associated mortality. Conclusions: The mortality for haemodialysis starters in England and Wales has declined over time, predominantly due to a reduction in cardiovascular mortality, with older people having the greatest reduction. However, sex, ethnicity, and social deprivation were not observed to affect mortality trends. Although mortality was lower, there was no comparable improvement in survival for peritoneal dialysis starters. Although cardiovascular mortality declined, as there was no change in infection associated mortality, greater attention is now required to reduce infection associated deaths.
- 6 July 2026
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
Open AccessTrends in mortality of people on dialysis in England and Wales over the last 15 years
Background: Traditionally cardiovascular death has been the major cause of death for kidney dialysis patients. Aim: To investigate trends in mortality over the past 15 years using UK Renal Registry (UKRR) data and the impact of age, sex, ethnicity and social deprivation. Methods: Incidence rates of all-cause mortality, cardiovascular mortality, mortality from infection and from dialysis withdrawal at 1 year after starting dialysis were calculated for incident patients. Comparisons by sex, deprivation-quintile and ethnicity used age-standardization to account for the change in the age profile over time. Results: All-cause mortality in haemodialysis patients within 1 year of starting reduced from 212/1000 patient years (py) in 2008 to 154 per 1000 py in 2022; although lower for peritoneal dialysis there was no improvement (67/1000 py to 82/1000 py). This decrease in mortality was greatest for older dialysis starters with no major changes in younger age-groups. There was no evidence of a difference in trends of all-cause or cardiovascular mortality by sex, ethnicity or deprivation quintiles. There was no improvement in infection associated mortality. Conclusions: The mortality for haemodialysis starters in England and Wales has declined over time, predominantly due to a reduction in cardiovascular mortality, with older people having the greatest reduction. However, sex, ethnicity, and social deprivation were not observed to affect mortality trends. Although mortality was lower, there was no comparable improvement in survival for peritoneal dialysis starters. Although cardiovascular mortality declined, as there was no change in infection associated mortality, greater attention is now required to reduce infection associated deaths.
- 19 May 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
Health inequalities and kidney disease: assessing equity across the renal care pathway using routinely collected data
Background: The impact of chronic kidney disease (CKD) is unevenly distributed across socio-demographic groups in England, contributing to disparities in healthcare access and outcomes. This study presents a baseline assessment of equity in renal care pathways across England, utilising health equity audit methodology, to facilitate future comparisons assessing intervention impact. Methods: This study used a retrospective, observational design. Data from three routinely available sources of healthcare activity data; CVDPREVENT, the Secondary Uses Service, and the UK Renal Registry (UKRR) were analysed to evaluate disparities in access to renal care pathways. More than twenty different dependent variables were analysed, by age, sex, ethnicity, socioeconomic status, and geography. We calculated the proportion of patients or rates per population for each category of explanatory variables. Results: The baseline equity assessment highlighted substantial disparities in access to kidney care across primary, secondary, and specialised services. Findings showed that; older adults faced lower access to transplants and peritoneal dialysis, while younger adults, particularly young men, were less likely to attend outpatient appointments. Socio-economic inequalities were evident, with patients from deprived areas having higher rates of late presentation and non-attendance, alongside reduced access to transplants and peritoneal dialysis. Asian patients demonstrated higher testing rates, whereas Black patients experienced higher non-attendance rates and lower transplant access. Conclusion: The study highlights the utility of the health equity audit for identifying inequities and provides a replicable methodology for local systems. Addressing these findings requires targeted interventions and systemic changes to reduce avoidable inequities and improve healthcare outcomes for all patients with CKD.
- 19 May 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
Health inequalities and kidney disease: assessing equity across the renal care pathway using routinely collected data
Background: The impact of chronic kidney disease (CKD) is unevenly distributed across socio-demographic groups in England, contributing to disparities in healthcare access and outcomes. This study presents a baseline assessment of equity in renal care pathways across England, utilising health equity audit methodology, to facilitate future comparisons assessing intervention impact. Methods: This study used a retrospective, observational design. Data from three routinely available sources of healthcare activity data; CVDPREVENT, the Secondary Uses Service, and the UK Renal Registry (UKRR) were analysed to evaluate disparities in access to renal care pathways. More than twenty different dependent variables were analysed, by age, sex, ethnicity, socioeconomic status, and geography. We calculated the proportion of patients or rates per population for each category of explanatory variables. Results: The baseline equity assessment highlighted substantial disparities in access to kidney care across primary, secondary, and specialised services. Findings showed that; older adults faced lower access to transplants and peritoneal dialysis, while younger adults, particularly young men, were less likely to attend outpatient appointments. Socio-economic inequalities were evident, with patients from deprived areas having higher rates of late presentation and non-attendance, alongside reduced access to transplants and peritoneal dialysis. Asian patients demonstrated higher testing rates, whereas Black patients experienced higher non-attendance rates and lower transplant access. Conclusion: The study highlights the utility of the health equity audit for identifying inequities and provides a replicable methodology for local systems. Addressing these findings requires targeted interventions and systemic changes to reduce avoidable inequities and improve healthcare outcomes for all patients with CKD.
- Open Access
- 20 March 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (4)
Heat-related acute kidney injury risk in England: a nationwide case-crossover analysis of 947 342 AKI alerts
Background: Acute kidney injury (AKI) incidence is rising and while heat–AKI associations are established, the demographic and clinical groups most vulnerable remain unclear. Identifying these groups is essential for kidney-specific heatwave guidance. Methods: A total of 947 342 AKI alerts in England from April to September 2017–21, from UK Renal Registry data, were linked to HadUK-Grid dataset and hospital admission data. We utilized a time-stratified, bidirectional case-crossover design with distributed lag models estimated odds ratios (ORs) for AKI associated with temperatures above 25°C, stratified by demographic characteristics and admission diagnosis. Results: Heat exposure was associated with AKI [OR 1.038; 95% confidence interval (CI) 1.036–1.040 per 1°C rise above 25°C] with highest odds for stage 3 AKI (OR 1.047; 95% CI 1.039–1.055). Associations were more marked in males (OR 1.041; 95% CI 1.037–1.044) than females (OR 1.035; 95% CI 1.032–1.039); odds doubled in those aged ≥85 years (OR 1.054; 95% CI 1.049–1.060) compared with the 45–64 years age group (OR 1.027; 95% CI 1.021–1.032). Ethnic risks varied between Chinese (OR 1.054, 95% CI: 1.012–1.098), White (OR 1.041; 95% CI 1.038–1.044), Indian (OR 1.033; 95% CI 1.019–1.047), Pakistani/Bangladeshi (OR 1.027; 95% CI 1.011–1.044), Caribbean (OR 1.024; 95% CI 1.005–1.042) and African (OR 1.001; 95% CI 0.982–1.021), with differences partly explained by younger age distribution in ethnic minority groups. Heat-related AKI was more marked for admissions of patients with delirium (OR 1.061; 95% CI 1.029–1.094) and with respiratory diseases (OR 1.044; 95% CI 1.037–1.052). Conclusions: There was effect modification by age for heat-related AKI risk, with especially high risks amongst older individuals; those admitted with delirium or respiratory illness and some ethnic groups. These findings support the development of targeted kidney-specific hot weather guidance to protect the vulnerable populations identified.
- 20 March 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (4)
Open AccessHeat-related acute kidney injury risk in England: a nationwide case-crossover analysis of 947 342 AKI alerts
Background: Acute kidney injury (AKI) incidence is rising and while heat–AKI associations are established, the demographic and clinical groups most vulnerable remain unclear. Identifying these groups is essential for kidney-specific heatwave guidance. Methods: A total of 947 342 AKI alerts in England from April to September 2017–21, from UK Renal Registry data, were linked to HadUK-Grid dataset and hospital admission data. We utilized a time-stratified, bidirectional case-crossover design with distributed lag models estimated odds ratios (ORs) for AKI associated with temperatures above 25°C, stratified by demographic characteristics and admission diagnosis. Results: Heat exposure was associated with AKI [OR 1.038; 95% confidence interval (CI) 1.036–1.040 per 1°C rise above 25°C] with highest odds for stage 3 AKI (OR 1.047; 95% CI 1.039–1.055). Associations were more marked in males (OR 1.041; 95% CI 1.037–1.044) than females (OR 1.035; 95% CI 1.032–1.039); odds doubled in those aged ≥85 years (OR 1.054; 95% CI 1.049–1.060) compared with the 45–64 years age group (OR 1.027; 95% CI 1.021–1.032). Ethnic risks varied between Chinese (OR 1.054, 95% CI: 1.012–1.098), White (OR 1.041; 95% CI 1.038–1.044), Indian (OR 1.033; 95% CI 1.019–1.047), Pakistani/Bangladeshi (OR 1.027; 95% CI 1.011–1.044), Caribbean (OR 1.024; 95% CI 1.005–1.042) and African (OR 1.001; 95% CI 0.982–1.021), with differences partly explained by younger age distribution in ethnic minority groups. Heat-related AKI was more marked for admissions of patients with delirium (OR 1.061; 95% CI 1.029–1.094) and with respiratory diseases (OR 1.044; 95% CI 1.037–1.052). Conclusions: There was effect modification by age for heat-related AKI risk, with especially high risks amongst older individuals; those admitted with delirium or respiratory illness and some ethnic groups. These findings support the development of targeted kidney-specific hot weather guidance to protect the vulnerable populations identified.
- Open Access
- 24 February 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (4)
Lower limb amputation in incident dialysis patients in England: incidence, outcomes and inter-centre variation from a national registry study
Background: Lower limb amputation (LLA) is a devastating complication in dialysis patients, often related to diabetes and peripheral vascular disease. National data on LLA incidence, variation and outcomes in England are limited. Methods: A retrospective cohort study conducted using linked data from the UK Renal Registry (UKRR) and Hospital Episode Statistics for incident dialysis patients in England (2003–17). Cumulative incidence plots assessed LLA rates across three patient subgroups: primary renal disease (PRD) diabetes, diabetes as comorbidity and no diabetes. Fine–Gray competing risk models identified independent risk factors for LLA. One-year mortality following LLA was presented as Kaplan–Meier curves and analysed using age- and sex-adjusted standardized mortality rates (SMRs). Results: Among 69 701 incident dialysis patients, 9.1% with PRD diabetes underwent LLA within 3 years, versus 2.6% with diabetes as comorbidity and 0.6% without diabetes. Risk factors for LLA included diabetes [subdistribution hazard ratio (sHR) 9.3 for PRD diabetes, sHR 3.6 for diabetes as comorbidity], peripheral vascular disease (sHR 2.11), prior amputation (sHR 2.19), ischaemic heart disease and White ethnicity. Major amputation rates declined over time, while minor amputation rates remained stable. Significant inter-centre variation was observed after adjustment. One-year mortality after LLA exceeded 40% in all subgroups. SMRs were highest in the PRD diabetes group compared with the general population (34.7), but highest in the diabetes as comorbidity group compared with the dialysis population (5.31). Conclusion: Incident dialysis patients, particularly those with PRD diabetes, face high LLA risk and very poor survival after amputation. Persistent inter-centre variation suggests scope for national audit, standardized foot care and preventive strategies.
- 24 February 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (4)
Open AccessLower limb amputation in incident dialysis patients in England: incidence, outcomes and inter-centre variation from a national registry study
Background: Lower limb amputation (LLA) is a devastating complication in dialysis patients, often related to diabetes and peripheral vascular disease. National data on LLA incidence, variation and outcomes in England are limited. Methods: A retrospective cohort study conducted using linked data from the UK Renal Registry (UKRR) and Hospital Episode Statistics for incident dialysis patients in England (2003–17). Cumulative incidence plots assessed LLA rates across three patient subgroups: primary renal disease (PRD) diabetes, diabetes as comorbidity and no diabetes. Fine–Gray competing risk models identified independent risk factors for LLA. One-year mortality following LLA was presented as Kaplan–Meier curves and analysed using age- and sex-adjusted standardized mortality rates (SMRs). Results: Among 69 701 incident dialysis patients, 9.1% with PRD diabetes underwent LLA within 3 years, versus 2.6% with diabetes as comorbidity and 0.6% without diabetes. Risk factors for LLA included diabetes [subdistribution hazard ratio (sHR) 9.3 for PRD diabetes, sHR 3.6 for diabetes as comorbidity], peripheral vascular disease (sHR 2.11), prior amputation (sHR 2.19), ischaemic heart disease and White ethnicity. Major amputation rates declined over time, while minor amputation rates remained stable. Significant inter-centre variation was observed after adjustment. One-year mortality after LLA exceeded 40% in all subgroups. SMRs were highest in the PRD diabetes group compared with the general population (34.7), but highest in the diabetes as comorbidity group compared with the dialysis population (5.31). Conclusion: Incident dialysis patients, particularly those with PRD diabetes, face high LLA risk and very poor survival after amputation. Persistent inter-centre variation suggests scope for national audit, standardized foot care and preventive strategies.
- Top Cited PapersOpen Access
- 10 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
KidneyGenAfrica multi-cohort Genome-wide association study and polygenic prediction of kidney function in 110,000 Africans
Kidney disease disproportionately affects populations of African ancestry, yet most genetic studies have focused on Europeans. Here, we present a three-stage genome-wide association study meta-analysis of estimated glomerular filtration rate in ~26,000 individuals across Eastern, Western, and Southern Africa and ~81,000 African-ancestry individuals in the diaspora. Continental African meta-analysis identifies four independent genome-wide significant loci, including two previously unreported loci. Pan-African meta-analysis identifies 19 independent loci, including three previously unreported loci. Fine-mapping reveals four loci with high causality probability, and phenome-wide analyses demonstrate pleiotropic effects on cardiometabolic and immunological traits. Notably, APOL1 high-risk variants strongly associated with kidney disease in African Americans show markedly lower frequency and attenuated effects in continental Africa, indicating potential distinct genetic architectures. Polygenic scores from genetically similar populations significantly outperformed those from distant cohorts. These findings demonstrate the necessity of conducting genomic research across diverse African populations to enable equitable health outcomes.
- 10 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Top Cited PapersOpen AccessKidneyGenAfrica multi-cohort Genome-wide association study and polygenic prediction of kidney function in 110,000 Africans
Kidney disease disproportionately affects populations of African ancestry, yet most genetic studies have focused on Europeans. Here, we present a three-stage genome-wide association study meta-analysis of estimated glomerular filtration rate in ~26,000 individuals across Eastern, Western, and Southern Africa and ~81,000 African-ancestry individuals in the diaspora. Continental African meta-analysis identifies four independent genome-wide significant loci, including two previously unreported loci. Pan-African meta-analysis identifies 19 independent loci, including three previously unreported loci. Fine-mapping reveals four loci with high causality probability, and phenome-wide analyses demonstrate pleiotropic effects on cardiometabolic and immunological traits. Notably, APOL1 high-risk variants strongly associated with kidney disease in African Americans show markedly lower frequency and attenuated effects in continental Africa, indicating potential distinct genetic architectures. Polygenic scores from genetically similar populations significantly outperformed those from distant cohorts. These findings demonstrate the necessity of conducting genomic research across diverse African populations to enable equitable health outcomes.
- Open Access
- 2 February 2026
- Published by BMJ in BMJ Medicine
- Vol. 5 (1) , e001950
Developing a new albuminuria-free risk prediction equation for kidney failure in patients with chronic kidney disease: retrospective cohort study
Objective: To develop new risk prediction equations for kidney failure in patients with chronic kidney disease who do not require data for the urine albumin to creatinine ratio. Design: Retrospective cohort study. Setting: Stockholm Creatinine Measurements (SCREAM) database of routinely collected electronic healthcare records in primary and outpatient care from the region of Stockholm, Sweden. Participants: 116 158 adults with chronic kidney disease stages 3-4, defined by two estimated glomerular filtration rate (eGFR) results of v 0.926, 0.915 to 0.936, for the new equation). KFRE under-estimated the risk in the study cohort, however, with an observed-expected event probability ratio of 2.11, suggesting that recalibration is required. Conclusions: The findings of the study indicate that predicting the risk of kidney failure with high accuracy in a general population of patients with chronic kidney disease is possible based on data that are routinely available, without requiring data for the urine albumin to creatinine ratio.
- 2 February 2026
- Published by BMJ in BMJ Medicine
- Vol. 5 (1) , e001950
Open AccessDeveloping a new albuminuria-free risk prediction equation for kidney failure in patients with chronic kidney disease: retrospective cohort study
Objective: To develop new risk prediction equations for kidney failure in patients with chronic kidney disease who do not require data for the urine albumin to creatinine ratio. Design: Retrospective cohort study. Setting: Stockholm Creatinine Measurements (SCREAM) database of routinely collected electronic healthcare records in primary and outpatient care from the region of Stockholm, Sweden. Participants: 116 158 adults with chronic kidney disease stages 3-4, defined by two estimated glomerular filtration rate (eGFR) results of v 0.926, 0.915 to 0.936, for the new equation). KFRE under-estimated the risk in the study cohort, however, with an observed-expected event probability ratio of 2.11, suggesting that recalibration is required. Conclusions: The findings of the study indicate that predicting the risk of kidney failure with high accuracy in a general population of patients with chronic kidney disease is possible based on data that are routinely available, without requiring data for the urine albumin to creatinine ratio.